Histopathologic and Preneoplastic Changes in Tubal Ligation Materials
- PMID: 38138220
- PMCID: PMC10744772
- DOI: 10.3390/medicina59122117
Histopathologic and Preneoplastic Changes in Tubal Ligation Materials
Abstract
Background and Objectives: To investigate histopathological changes and serous carcinoma precursors such as secretory cell outgrowths (SCOUTs) and p53 signature in the bilateral tubal ligation (BTL) materials used during cesarean section (S/C). Materials and Methods: In total, 138 patients underwent S/C and tubal sterilization (TS) between October 2020 and May 2021 at Konya City Hospital. Patients' data were obtained from the hospital's system. All data and findings were investigated and statistically evaluated. Results: The mean age was 34.62 years (22-44), the mean gravity was 4.89 (2-15) and the mean parity was 3.46 (1-10). In total, 5.79% SCOUT, 7.24% atypia and 9.42% p53 signatures were observed. Significant correlations were shown between the epithelial cell lineage and age between Ki-67, SCOUT, and gravity; between the Ki-67 results and gravity and parity; and between the p53 score and age. Conclusions: TS is a common, safe, and effective method worldwide. Today, BTL is increasing along with increasing S/C ratios. In addition to the reduced risk of ovarian cancers with ligation alone, precursor lesions such as hyperplasia, SCOUT, p53 signature, and STIL/Serous tubal intraepithelial carcinoma (STIC) are encountered in the ampulla materials obtained. Considering the low rates of re-anastomosis, tubal excision may be recommended instead of ligation in women of relatively higher gravity and age.
Keywords: SCOUT; epithelial hyperplasia; p53 signature; tubal ligation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
[Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):433-7. doi: 10.3760/cma.j.issn.0529-5807.2012.07.001. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22932451 Chinese.
-
Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):481-488. doi: 10.4103/0377-4929.191789. Indian J Pathol Microbiol. 2016. PMID: 27721278
-
Prevalence of precursor lesions (P53 signature, SCOUT, STIL, STIC) in fallopian tubes resected for non-neoplastic causes.Indian J Pathol Microbiol. 2022 Jul-Sep;65(3):610-616. doi: 10.4103/ijpm.ijpm_529_21. Indian J Pathol Microbiol. 2022. PMID: 35900489
-
Serous tubal intra-epithelial carcinoma: what do we really know at this point?Histopathology. 2022 Nov;81(5):542-555. doi: 10.1111/his.14722. Epub 2022 Aug 4. Histopathology. 2022. PMID: 35859323 Review.
-
[Fallopian tube: the dark face of pelvic carcinogenesis].Ann Pathol. 2011 Oct;31(5):345-52. doi: 10.1016/j.annpat.2011.06.008. Epub 2011 Sep 25. Ann Pathol. 2011. PMID: 21982240 Review. French.
References
-
- Sung S., Abramovitz A. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2022. Tubal Ligation. - PubMed
-
- Şentürk M.B., Budak M.S., Toğrul C., Tahaoğlu A.E., Balsak D., Akgöl S. The Pregnancy Rates After Tubal Reanastomosis. Okmeydanı Tıp Derg. 2016;32:79–82. doi: 10.5222/otd.2016.1044. - DOI
-
- Özkan H., Özer B.U., Arı Ö. Sezaryen İle Doğuma Güncel Bir Bakış: Modern Sezaryen Teorisi. Arşiv Kaynak Tarama Derg. 2021;30:226–235.
-
- Uaamnuichai S., Phutrakool P., Thammasitchai N., Sathitloetsakun S., Santibenchakul S., Jaisamrarn U. Does socioeconomic factors and healthcare coverage affect postpartum sterilization uptake in an urban, tertiary hospital? Reprod. Health. 2023;20:23. doi: 10.1186/s12978-023-01572-5. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous